Microglia and TAMs are hypothesized to hold different roles in glioblastoma, with the presence of microglia and TAMs within the tumor potentially differentially affecting patient survival.23 Therefore, using the quantification of microglia and TAMs based on P2RY12 and TMEM119 immunoreactivity, we investigated potential correlations with patient survival. The gene discussed is TMEM119; the disease is neoplasm.